Multiomics integration prioritizes potential drug targets for multiple sclerosis

Journal:
Proceedings of the National Academy of Sciences of the United States of America
Published:
DOI:
10.1073/pnas.2425537122
Affiliations:
6
Authors:
8
Go to article
Institutions Authors Share
Karolinska Institute (KI), Sweden
4.000000
 0.50
Center for Molecular Medicine (CMM), Sweden
3.666667
 0.46
West China School of Public Health /West China Fourth Hospital, SCU, China
0.333333
 0.04
Interested in Neurosciences?